Intentional shoppers nationwide pushed back against Amazon and B&N’s late April sales by visiting their local independent ...

In a study presented at DDW 2025, researchers examined how complications from IBD differ between Black and White patients across the United States.

LandBridge stock has formed an early stage base after earnings. Shares have outperformed 97% of other stocks in the IBD ...

"With IBD management becoming increasingly individualized, we anticipate these analyses will help clarify how ZYMFENTRA performs across a wide range of patient types, from long-term drug ...

The research also predicts inflammatory bowel disease diagnoses will likely double in Aotearoa in the next 20 years.

Molecular-guided decision-making improves disease control and remission in the treatment of IBD with anti-TNF therapy, however, application to other therapies is questioned.

Obesity was associated with lower odds of steroid-free clinical remission in patients with inflammatory bowel disease (IBD) at week 24 after the initiation of treatment. "In clinical practice ...

In time for May, which is Inflammatory Bowel Disease Awareness month, Crohn’s & Colitis Australia (CCA) have launched a ...

Upadacitinib shows sustained efficacy and consistent safety for moderate to severe ulcerative colitis in long-term trials and ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”) announced today that its NAMkind™ platform for intestinal efficacy prediction was recognized with ...

The two major types of IBD―Crohn’s disease and ulcerative colitis―present with overlapping but distinct symptoms. Crohn’s ...

(RTTNews) - Spyre Therapeutics, Inc. (SYRE), a clinical-stage biotech company focused on innovative antibody therapies for Inflammatory Bowel Disease or IBD and ... Disease Week or DDW 2025 ...